BioCentury
ARTICLE | Financial News

GeneFormatics raises $22 million

October 17, 2001 7:00 AM UTC

GeneFormatics (San Diego, Calif.), which is using in silico technologies to analyze human protein sequences and pathogen proteomes, raised $22 million in a private financing. Investors included Bruker AXS; Bruker BioSpin; Bruker Daltonics (BDAL); TaKaRa Shuzo; China Development Industrial Bank; Perseus-Soros BioPharmaceutical Fund; Merrill Lynch Ventures; Orbimed Advisors; Burrill & Co; GeneChem; Inglewood Ventures; and Moss Forest Venture. ...